Atlas FDA

VISITAG SURPOINT External Processing Unit (EPU)

FDA premarket approval P030031/S110 · decided 2021-11-12

Approval details

PMA number
P030031
Supplement
S110
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VISITAG SURPOINT External Processing Unit (EPU)
Generic name
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
Applicant
Biosense Webster, Inc.
Date received
2020-11-20
Decision date
2021-11-12
Days to decision
357 days
Decision code
APPR
Product code
OAD
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for changes to the Indications for Use and the Instructions for Use (IFU) for the VISITAG SURPOINT External Processing Unit (EPU).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CARTO™ 3 EP Navigation System V8.4 (K252972)Biosense Webster, Inc.2026-02-20
CARTO™ 3 EP Navigation System V9.0 with PIU Plus (K254085)Biosense Webster, Inc.2026-01-18
CARTO™ 3 EP Navigation System V8.1 (K252302)Biosense Webster, Inc.2025-08-22
NUVISION™ Ultrasound Catheter; NUVISION™ NAV Ultrasound Catheter (K241540)Biosense Webster, Inc.2024-06-28
SOUNDSTAR™ CRYSTAL Ultrasound Catheter (K240050)Biosense Webster, Inc.2024-06-12
CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) (K231207)Biosense Webster, Inc.2023-09-07
PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID (K231312)Biosense Webster, Inc.2023-07-10
CARTO VIZIGO® 8.5F Bi-Directional Guiding Sheath (D-1385-01-S, D-1385-02-S, D-1385-03-S) (K231412)Biosense Webster, Inc.2023-07-10